secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIT MEDICAL SYSTEMS INC (MMSI)
CIK:        0000856982
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0000856982-25-000041
Event type: leadership
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merit Medical names Martha Aronson as CEO effective Oct 3; preliminary Q2 revenue up ~12-14% YoY
--------------------------------------------------------------------------------

- Martha Aronson appointed President and CEO effective Oct 3, 2025; founder Fred Lampropoulos remains Chairman.
- Aronson previously EVP & President of Global Healthcare at Ecolab; 20 years at Medtronic.
- Compensation: $1M base salary, $250K signing bonus, target bonus 100% of base, $5.5M initial LTI award, $4.125M equity grant.
- Preliminary Q2 2025 revenue $380-384M, up 12-14% YoY; constant currency up 11-13%.
- Full Q2 earnings release scheduled for July 30, 2025 after market close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000041/0000856982-25-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000041/mmsi-20250707x8k.htm
  HTML page:      https://secwatch.observer/filing/0000856982-25-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer